Baxano Surgical Inc (BAXSQ) 0.0040 $BAXSQ Inivata

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Baxano Surgical Inc (BAXSQ) 0.0040 $BAXSQ

Inivata Announces Appointment of Timothy Shannon as Chief Financial Officer
PR Newswire - Mon Aug 01, 1:00AM CDT
Inivata, a global clinical cancer genomics company employing the precision of circulating tumor DNA (ctDNA) analysis to improve personalized healthcare in oncology, today announces the appointment of Timothy Shannon as Chief Financial Officer. Tim will be based out of Inivata's US Research Triangle Park (RTP) office with global responsibilities for Inivata's financial and operational management.

Experienced Healthcare Executive Ken Reali Joins Clinical Innovations as New CEO
BusinessWire - Mon Jun 01, 10:34AM CDT
Clinical Innovations, a member of Pritzker Group Private Capital's family of companies and the largest healthcare manufacturer exclusively focused on labor and delivery, today announced the appointment of Ken Reali as its president and chief executive officer.
SNN: 32.51 (-0.55)

U.S. Minimally Invasive Spinal Implant Market - 2015 Executive Summary
M2 - Fri Jan 09, 8:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/lkvb2c/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015 (Executive Summary)" report to their offering. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Key Topics Covered: - U.S. Minimally Invasive Spinal Implant Market - Spinous Process Fixation Market - Facet Fixation Market - Mis Interbody Fusion Market - Mis Pedicle Screw Market - Mis Sacroiliac Joint Fusion Market - Leading Competitors Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/lk..._minimally
MDT: 84.84 (-1.36), GMED: 22.65 (-0.55)

2015 U.S. Minimally Invasive Spinal Implant Market Report
M2 - Thu Jan 08, 10:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/dp4wpm/u_s_minimally) has announced the addition of the "U.S. Minimally Invasive Spinal Implant Market - 2015" report to their offering. The U.S. market for minimally invasive surgery (MIS) spinal implants includes spinous process fixation, facet fixation, MIS interbody fusion, MIS pedicle screws and MIS sacroiliac joint fusion. This U.S. Minimally Invasive Spinal Implant Market report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Growth in the minimally invasive spinal implant market is largely driven by the advantages of minimally invasive surgery over open surgery; these include reduced trauma, shorter hospital stays, lower post-operative medication use and earlier return to work. However, growth is expected to slow over the forecast period as a result of the increasing penetration of MIS procedures into the traditional fusion market and increases in the competing motion preservation market. The vast majority of patients, when given the option, will choose minimally invasive procedures rather than traditional open fusion surgeries. Patients are drawn to the advantages of less invasive techniques. MIS reduces muscle and tissue damage at the surgical site, decreases complications and limits intraoperative time. Clinical outcomes have been largely positive, further favoring the use of MIS techniques over open procedures. From a practice standpoint, more surgeons are looking into MIS approaches to not only market their practice competitively, but also to increase their potential revenues. MIS procedures often require less intraoperative and hospital time for the patient. As a result, surgeons would theoretically be able to perform more procedures within the same allotted amount of time than if they were to perform the procedures via an open approach. Report Highlights: - Discusses changes to reimbursement policies among healthcare insurers will drastically change the market landscape - Recent introduction of spinous process fixation devices - Recent policy changes effecting the spinous process fixation market - Emerging technology in the minimally invasive surgery field - Pricing pressures driven by hospitals and insurance providers will effect the MIS Interbody Fusion Market - MIS Sacroiliac Joint Fusion Market change to a category I CPT code Companies Mentioned - Alphatec Spine - Amedica - Baxano Surgical - Biomet - DePuy Synthes - Globus Medical - Interventional Spine - K2M - Medtronic - NuVasive - Nutech - Orthofix - OsteoMed - Pioneer Surgical - SI-BONE - Stryker - VG Innovations - Zimmer - Zyga Technology For more information visit http://www.researchandmarkets.com/research/dp..._minimally
MDT: 84.84 (-1.36), GMED: 22.65 (-0.55)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 69

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 573

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 343

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 158

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 587

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 116

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 437

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 131

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 265

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 24

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading

Top 5 Most Recently Viewed Articles

WISeKey Enhances Digital ID Solutions Across Africa

Updated Category News Views 199

WISeKey Expands Its Digital Identity Footprint Across Africa WISeKey International Holding Ltd is making significant strides in transforming digital identity solutions not only within Seychelles but also expanding into several other African nations. As a prominent player in cybersecurity, blockchain, and IoT, WISeKey is set to revolutionize how national ID systems...

Continue Reading
How to Send Event Leads Directly into Your CRM

Updated Category Business Views 149

Trade shows and conferences generate some of the highest-intent leads a sales team will ever encounter. Yet many of those conversations never convert—not because the prospect lost interest, but because the follow-up arrived too late or the contact details were lost somewhere between a badge scanner and a spreadsheet. Research from event marketing surveys consistently...

Continue Reading
Dreame Technology's Innovative Smart Home Solutions at CES 2025

Updated Category News Views 474

Dreame Technology Showcases Innovative Solutions at CES 2025 Dreame Technology, a pioneer in smart home solutions, has made waves at CES 2025 with the introduction of its next-generation smart home ecosystem. This new system streamlines home management and enhances everyday living through intelligent appliances that are easy to use and highly efficient. Revolutionizing...

Continue Reading
Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 374

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Cocoa Prices Plummet, Boosting Chocolate Makers Before Holidays

Updated Category News Views 253

Cocoa Prices Reach New Lows Recently, cocoa futures dropped to their lowest point in nearly two years, which is quite timely as we approach the season for hot chocolate and festive gifting. This price decline acts as a unique advantage for chocolate manufacturers who are just starting to see some relief after facing escalating ingredient costs over the past year, coupled...

Continue Reading